BCX7353-204 APeX-S for HAE
No More Needles to Prevent HAE Attacks? We need you to help us find out.
Right now, patients are being enrolled in the APeX-S study, a worldwide clinical research study to investigate the long-term safety of an investigational oral medication to prevent hereditary angioedema (HAE) attacks.
If you have Type I or II HAE and are interested in learning about an oral medication that could become an alternative to injections or infusions to prevent attacks, then see if you qualify.
You can find additional information about APeX-S at [email protected]
